Diabetes and Nerve Damage

What Is Diabetic Neuropathy? Types, Causes, and Scope

The connection between diabetes and nerve damage — collectively called diabetic neuropathy — represents the most common complication of diabetes, affecting approximately 50% of people with diabetes over the course of their lifetime. Neuropathy encompasses a wide range of nerve disorders caused by the toxic effects of chronically elevated blood glucose on nerve fibers and the small blood vessels (vasa nervorum) that supply them with oxygen and nutrients. The consequences range from uncomfortable tingling and burning pain to life-altering loss of sensation, impaired organ function, and dramatically elevated risk of limb-threatening foot ulcers. Understanding the different types of diabetic neuropathy, their symptoms, and the evidence-based treatments available is essential for everyone living with diabetes. Our guide on what is diabetes covers foundational concepts; this article focuses on the full spectrum of diabetic nerve damage and its management.

Diabetic neuropathy is not a single condition but a family of nerve disorders that differ in which nerves are affected, the pattern of symptoms, and the clinical consequences:

Peripheral neuropathy (distal symmetric polyneuropathy): The most common form, affecting the longest peripheral nerves first — those supplying the feet and lower legs — in a characteristic “stocking-glove” distribution. As disease progresses, the hands and forearms become involved. Peripheral neuropathy causes numbness, tingling, burning pain, hypersensitivity, and eventually loss of protective sensation.
Autonomic neuropathy: Damage to the autonomic nervous system — which controls involuntary functions including heart rate, blood pressure, digestion, bladder function, and sexual response. Autonomic neuropathy can manifest as cardiovascular autonomic neuropathy (abnormal heart rate responses, orthostatic hypotension), gastroparesis (delayed stomach emptying), bladder dysfunction, erectile dysfunction, and hypoglycemia unawareness.
Focal and multifocal neuropathies: Damage to individual nerves (mononeuropathies) or nerve roots (radiculopathies), often with a sudden onset and gradual recovery. Examples include diabetic amyotrophy (severe pain and weakness in the thigh), carpal tunnel syndrome (median nerve compression at the wrist — more common in people with diabetes), and cranial nerve palsies causing double vision or facial weakness.
Proximal neuropathy (diabetic amyotrophy): A particularly painful form affecting nerves of the hip, thigh, and buttocks, causing severe unilateral pain and muscle weakness. It typically begins asymmetrically, can cause significant disability, and often improves over months to years with improved blood glucose control.

How Common Is Diabetic Neuropathy? Approximately 50% of people with diabetes will develop neuropathy over their lifetime, making it the most prevalent chronic complication of diabetes. Peripheral neuropathy is present in roughly 30–50% of people with Type 2 diabetes at 10 years after diagnosis. Autonomic neuropathy affecting at least one autonomic function is estimated to be present in 20–40% of people with diabetes. Neuropathy is the leading cause of non-traumatic lower limb amputation in the world — with diabetic peripheral neuropathy contributing to the majority of the 85% of diabetes-related amputations that are preceded by a foot ulcer.

Symptoms of Diabetic Peripheral Neuropathy

The sensory symptoms of peripheral neuropathy vary considerably between individuals and may include a mix of positive symptoms (things people feel that shouldn’t be there) and negative symptoms (loss of sensation that should be present):

Numbness and reduced sensation: The insidious loss of protective sensation in the feet — the ability to feel pain, temperature, and pressure — is the most dangerous symptom of peripheral neuropathy because it allows injuries to go undetected. People step on sharp objects, develop blisters from tight shoes, or sustain burns from hot water without feeling anything. These undetected injuries can progress to infected ulcers and, ultimately, amputation.
Tingling and “pins and needles”: Paresthesias in the feet and toes — often described as tingling, crawling, or electrical buzzing sensations — are frequently the earliest reported symptom of peripheral neuropathy. They are caused by abnormal spontaneous electrical activity in damaged nerve fibers.
Burning pain: Many people with painful diabetic neuropathy describe a burning, aching, or stabbing pain in the feet and lower legs that is often worse at night and can severely disrupt sleep. This neuropathic pain results from aberrant pain signaling in damaged nerve fibers and can be debilitating even when the foot appears entirely normal on visual inspection.
Hypersensitivity (allodynia): Some people experience hypersensitivity to normally non-painful stimuli — the weight of bed sheets on the feet, light touch, or changes in temperature causing intense discomfort. This allodynia is a hallmark of small fiber neuropathy and certain painful neuropathy subtypes.
Muscle weakness and balance problems: As motor nerve fibers are affected, weakness in the intrinsic foot muscles causes clawing of the toes, altered foot mechanics, and redistribution of pressure on the plantar surface — predisposing to calluses and ulcers at pressure points. Impaired proprioception (sense of position) causes balance instability and increases fall risk, particularly in older adults.

Our guide on tingling feet and diabetes — if available — provides additional detail on the early sensory symptoms that often prompt people to seek evaluation for neuropathy.

healthcare provider performing monofilament foot sensation test on a patient with diabetic peripheral neuropathy — The 10-gram monofilament test assesses protective sensation in the diabetic foot — loss of the ability to feel the monofilament indicates significant peripheral neuropathy and markedly elevated risk for undetected foot injury and ulceration.

Autonomic Neuropathy: When the Nervous System’s “Autopilot” Fails

Autonomic neuropathy is often less visible than peripheral neuropathy but can be equally — or more — disabling and life-threatening. The autonomic nervous system controls the body’s involuntary functions, and when diabetes damages autonomic nerves, virtually any organ system can be affected:

Cardiovascular Autonomic Neuropathy (CAN)

CAN is the most clinically serious form of autonomic neuropathy and is associated with a two-fold increased risk of cardiovascular mortality in people with diabetes. Manifestations include resting tachycardia (elevated heart rate at rest due to loss of parasympathetic tone), orthostatic hypotension (blood pressure drop on standing causing dizziness and falls), reduced heart rate variability, and exercise intolerance. People with CAN may have “silent myocardial infarctions” — heart attacks without chest pain — because cardiac pain is transmitted by autonomic nerve fibers that are damaged. This makes cardiovascular monitoring especially important in people with established autonomic neuropathy. Our guide on diabetes and heart disease covers the cardiovascular complications context within which CAN occurs.

Gastroparesis

Diabetic gastroparesis — delayed gastric emptying due to damage to the vagus nerve — causes nausea, vomiting, early satiety, bloating, and erratic postprandial blood glucose levels (because the timing of glucose absorption becomes unpredictable when stomach emptying is delayed and variable). It occurs in approximately 5–12% of people with long-standing diabetes and can significantly impair nutrition, quality of life, and glycemic control. Treatment includes dietary modification (small, frequent, low-fat, low-fiber meals), prokinetic medications (metoclopramide, domperidone), and in severe cases, gastric electrical stimulation or feeding tubes.

Bladder Dysfunction

Diabetic cystopathy — autonomic damage to the bladder — initially causes reduced bladder sensation (failure to detect a full bladder), followed by impaired detrusor muscle contractions and incomplete bladder emptying. This causes urinary retention with overflow incontinence and dramatically increased risk of urinary tract infections from stagnant urine. People with diabetes who develop recurrent UTIs should be evaluated for bladder dysfunction.

Hypoglycemia Unawareness

Autonomic neuropathy affecting the adrenergic warning system prevents people from recognizing hypoglycemia — they lose the sweating, trembling, and heart pounding that normally signal low blood glucose, and may deteriorate directly to severe confusion or unconsciousness without warning. This is a dangerous complication that requires modified glucose targets, careful medication adjustments, and continuous glucose monitoring. Our guide on low blood sugar: what to do covers hypoglycemia recognition and response.

Treatment of Diabetic Neuropathy: Pain Management and Nerve Protection

Treatment of diabetic neuropathy focuses on two distinct goals: preventing progression through blood glucose optimization, and managing symptoms (particularly pain) that affect quality of life.

Blood Glucose Control: The Only Disease-Modifying Treatment

Intensive blood glucose control remains the only intervention proven to prevent the development and slow the progression of diabetic peripheral neuropathy. The DCCT trial demonstrated that intensive insulin therapy reduced the incidence of neuropathy by 60% in Type 1 diabetes. For Type 2 diabetes, the evidence is somewhat more modest — glucose control prevents early neuropathy but has less dramatic effects on established disease. This underscores the importance of early and sustained glycemic optimization before neuropathy becomes irreversible. Our guide on Type 2 diabetes: causes and diagnosis covers HbA1c targets and the glucose management that is central to neuropathy prevention.

Pharmacological Pain Management

Several medication classes are FDA-approved or guideline-recommended for painful diabetic peripheral neuropathy:

Duloxetine (Cymbalta): A serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant, duloxetine is FDA-approved for painful diabetic neuropathy and is typically the first-line pharmacological option. It reduces neuropathic pain by modulating descending pain inhibition pathways in the spinal cord.
Pregabalin (Lyrica) and gabapentin (Neurontin): Alpha-2-delta calcium channel ligands that reduce the release of excitatory neurotransmitters in hyperexcited neuropathic pain circuits. Pregabalin is FDA-approved for painful diabetic neuropathy; gabapentin is used off-label. Both can cause drowsiness, dizziness, and weight gain, and require dose adjustment in kidney disease.
Tricyclic antidepressants (amitriptyline, nortriptyline): Older antidepressants that modulate pain pathways and are effective for neuropathic pain, though their anticholinergic side effects (dry mouth, constipation, urinary retention, cognitive effects) limit their use, particularly in older adults.
Topical treatments: Capsaicin cream (which depletes substance P in pain nerve endings) and lidocaine patches can provide localized pain relief with minimal systemic side effects, making them useful for people who cannot tolerate oral medications.
Sodium channel blockers: Certain antiepileptic drugs (carbamazepine, oxcarbazepine) are used for lancinating neuropathic pain, particularly in focal neuropathies.

Pain management for diabetic neuropathy often requires trial and adjustment — no single medication works for all patients, and combination therapy is frequently necessary. A pain specialist or neurologist may be helpful for people with severe or refractory neuropathic pain.

Diagnosing Diabetic Neuropathy: Tests and Clinical Assessment

The diagnosis of diabetic peripheral neuropathy is primarily clinical, based on the combination of symptoms, physical examination findings, and exclusion of other causes of neuropathy. A thorough evaluation includes:

Clinical History

The clinician will ask about the pattern of symptoms — their onset, location, character (burning, tingling, numbness), timing (worse at night?), and severity. Duration of diabetes, glycemic control history, and the presence of other complications help contextualize the clinical picture. Because many conditions other than diabetes can cause peripheral neuropathy (hypothyroidism, B12 deficiency, alcohol use, certain medications including some chemotherapeutics, and hereditary neuropathies), a complete history is necessary to determine whether the neuropathy is truly diabetic in origin.

Physical Examination

The standard clinical assessment for diabetic peripheral neuropathy includes:

10-gram monofilament test: A standardized filament that bends at exactly 10 grams of pressure is applied to multiple points on the plantar surface of the foot. Inability to feel the monofilament at multiple points indicates loss of protective sensation and significantly elevated foot ulcer risk. This is the most important clinical screening test for diabetic neuropathy.
Vibration perception with a 128-Hz tuning fork: Applied to the great toe and medial malleolus, this tests large fiber nerve function. Reduced or absent vibration perception is one of the earliest detectable signs of peripheral neuropathy on examination.
Temperature sensation: The ability to feel hot and cold is mediated by small nerve fibers and is often impaired early in diabetic neuropathy.
Ankle reflexes: The Achilles tendon reflex is often reduced or absent in diabetic peripheral neuropathy due to damage to the sensory afferents that carry the reflex arc.
Proprioception testing: Assessing the ability to detect passive movement of the toes identifies proprioceptive impairment that contributes to balance problems and fall risk.

Nerve Conduction Studies and Electromyography (NCS/EMG)

For cases where the diagnosis is uncertain, where neuropathy is asymmetric, or where a different type of neuropathy is suspected, nerve conduction studies (NCS) and electromyography (EMG) can characterize the pattern of nerve dysfunction precisely — distinguishing axonal from demyelinating neuropathy, identifying focal compressions (such as carpal tunnel), and quantifying the severity of nerve damage. These specialized neurophysiological tests are performed by neurologists and are not required for the diagnosis of straightforward distal symmetric diabetic peripheral neuropathy.

Monitoring for Neuropathy: How Often and What to Watch For

The ADA recommends annual screening for peripheral neuropathy in all people with diabetes, beginning at diagnosis for Type 2 diabetes and after 5 years for Type 1 diabetes. The standard annual foot examination should include monofilament testing, vibration sensation, ankle reflexes, and visual inspection of the feet. Autonomic neuropathy screening should include assessment for orthostatic hypotension (blood pressure measured lying and standing), and inquiries about symptoms of gastroparesis, bladder dysfunction, and sexual dysfunction. People with established neuropathy and loss of protective sensation require more frequent foot examinations (every 1–3 months) due to the high risk of foot injury and ulceration.

It is important for people with diabetes to be aware of the gradual nature of neuropathy progression and to self-monitor for changes. Daily foot inspection — looking for cuts, blisters, redness, swelling, or any skin breakdown — is strongly recommended for everyone with sensory neuropathy and loss of protective sensation, because these individuals cannot rely on pain to alert them to foot injuries. Our guide on diabetes and foot health covers the daily foot care practices and warning signs that are critical complements to neuropathy monitoring.

Non-Pharmacological Approaches to Managing Neuropathic Pain

Beyond medications, several non-pharmacological interventions have evidence for reducing neuropathic pain and improving function in people with diabetic peripheral neuropathy:

Physical therapy and exercise: Regular moderate-intensity aerobic exercise has been shown to improve neuropathic pain, balance, and quality of life in people with diabetic peripheral neuropathy. Exercise appears to promote nerve fiber regeneration in the skin, stimulate anti-inflammatory mechanisms, and improve peripheral blood flow. Walking, cycling, and swimming are well-tolerated options; water-based exercise is particularly useful for people with significant foot sensitivity. Our guide on sedentary lifestyle and blood sugar covers the broader metabolic benefits of regular physical activity in diabetes.
Balance and fall prevention training: For people with proprioceptive impairment and balance instability, balance training programs — including tai chi, proprioceptive exercises, and vestibular rehabilitation — reduce fall risk significantly. Falls are a major source of injury and loss of independence in older adults with diabetes and neuropathy, and fall prevention is an important component of comprehensive neuropathy management.
Transcutaneous electrical nerve stimulation (TENS): TENS devices deliver mild electrical currents through skin electrodes and can provide short-term pain relief in some people with neuropathic pain through gate control mechanisms. Evidence quality is modest but TENS is safe and may be a useful adjunct to pharmacological pain management.
Cognitive behavioral therapy (CBT) and pain psychology: Chronic neuropathic pain has a significant psychological component — catastrophizing, pain-related fear, and depression amplify the perceived intensity of neuropathic pain and reduce functional capacity. CBT and mindfulness-based stress reduction programs that address these psychological factors can meaningfully reduce pain severity and improve function even without reducing the underlying nerve damage.
Dietary approaches: A low-fat, plant-based diet has been studied specifically for painful diabetic neuropathy in a small but well-designed trial and showed significant pain reduction alongside improvements in blood glucose and weight. The mechanisms likely include both improved glycemic control and reduced inflammatory burden. While not yet standard of care, dietary pattern improvements that support glucose control also support neuropathic pain management.

The Link Between Neuropathy and Other Diabetes Complications

Diabetic peripheral neuropathy does not exist in isolation — it is part of a broader pattern of microvascular disease that also includes retinopathy and nephropathy. The same mechanisms of blood vessel damage and nerve fiber degeneration driven by chronic hyperglycemia affect the kidneys, eyes, and nerves simultaneously. People with significant peripheral neuropathy are substantially more likely to also have retinopathy and nephropathy, and screening for these conditions should be coordinated. Our guides on diabetes and eye health and diabetes and kidney health cover the parallel monitoring that should accompany neuropathy assessment in comprehensive diabetes care.

The relationship between neuropathy and cardiovascular risk is also clinically important. Cardiovascular autonomic neuropathy is independently associated with increased cardiovascular mortality. Peripheral neuropathy that causes reduced activity and loss of muscle mass can contribute to worsening insulin resistance and metabolic decompensation. And the chronic pain of painful neuropathy is associated with depression, sleep disturbance, reduced physical activity, and impaired glycemic control — creating a vicious cycle in which neuropathy worsens the metabolic state that drives further neuropathy progression. Addressing neuropathy is therefore not just about nerve health in isolation but about the broader metabolic and quality-of-life context of comprehensive diabetes management. Our guide on diabetes and heart disease covers the cardiovascular monitoring that complements neuropathy care.

The Most Important Step: Early Blood Glucose Control No medication can reverse established diabetic nerve damage — the neuropathy treatments described above manage symptoms and slow progression, but do not restore nerve fibers that have already been destroyed. This makes early and sustained blood glucose control the most important intervention for neuropathy prevention. People newly diagnosed with diabetes who achieve and maintain HbA1c targets in the first years of their condition can largely avoid the development of significant peripheral neuropathy. People with established neuropathy who improve glycemic control can slow further progression and, in some cases, achieve modest improvement in small fiber nerve density. The window of opportunity for prevention is early — starting glucose management at diagnosis, not years later after symptoms appear.

When to Seek Specialist Care for Diabetic Neuropathy

While primary care providers and diabetes care teams manage most cases of diabetic neuropathy, specialist referral is appropriate in several situations: when the neuropathy pattern is atypical (asymmetric, rapidly progressive, or involving cranial nerves), when the diagnosis is uncertain and other causes of neuropathy need to be excluded, when pain is severe and unresponsive to standard treatments, or when autonomic neuropathy is causing significant cardiovascular instability, gastroparesis, or bladder dysfunction. A neurologist can perform specialized testing and guide management for complex neuropathy cases. A pain medicine specialist can help with refractory neuropathic pain. A gastroenterologist is appropriate for confirmed or suspected gastroparesis. Working collaboratively across specialties ensures that the full spectrum of diabetic nerve damage is managed with the most evidence-based approaches available. Seeking help earlier rather than later leads to better outcomes, since established nerve damage cannot be reversed — only further progression can be slowed.

Sources: American Diabetes Association. “Retinopathy, Neuropathy, and Foot Care.” Diabetes Care 2024. | NIDDK — Diabetic Neuropathies. | Mayo Clinic — Diabetic Neuropathy. | American Academy of Neurology — Neuropathy Guidelines. | Pop-Busui R, et al. “Diabetic Neuropathy: A Position Statement by the American Diabetes Association.” Diabetes Care 2017.